Systemic administration of baclofen and the GABAB antagonist, CGP 35348, does not affect GABA, glutamate or aspartate in microdialysates of the striatum of conscious rats

This publication has 15 references indexed in Scilit:

• Weak effects of local and systemic administration of the GABA uptake inhibitor, SK&F 89976, on extracellular GABA in the rat striatum
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1992
• In vivo characterisation of extracellular dopamine, GABA and acetylcholine from the dorsolateral striatum of awake freely moving rats by chronic microdialysis
  Journal of Neuroscience Methods, 1991
• CGP 35348: a centrally active blocker of GABAB receptors
  European Journal of Pharmacology, 1990
• An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats
  Journal of Neuroscience Methods, 1990
• Presynaptic GABA Receptors
  Annals of the New York Academy of Sciences, 1990
• Characterization of gamma-aminobutyric acid and dopamine overflow following acute implantation of a microdialysis probe
  Life Sciences, 1989
• Studies on [3H] GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type
  European Journal of Pharmacology, 1987
• Baclofen: Effects on evoked field potentials and amino acid neurotransmitter release in the rat olfactory cortex slice
  Brain Research, 1982
• Baclofen: Inhibition of the release of l-[3H]glutamate and l-[3H]aspartate from rat whole brain synaptosomes
  General Pharmacology: The Vascular System, 1982
• Baclofen: effects on amino acid release
  Canadian Journal of Physiology and Pharmacology, 1978